相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CRISPR-based genome editing through the lens of DNA repair
Tarun S. Nambiar et al.
MOLECULAR CELL (2022)
Long-term outcomes of lentiviral gene therapy for the β-hemoglobinopathies: the HGB-205 trial
Elisa Magrin et al.
NATURE MEDICINE (2022)
Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease
Julie Kanter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Acute Myeloid Leukemia Case after Gene Therapy for Sickle Cell Disease
Sunita Goyal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2022)
Comprehensive analysis of prime editing outcomes in human embryonic stem cells
Omer Habib et al.
NUCLEIC ACIDS RESEARCH (2022)
Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin
Nithin Sam Ravi et al.
ELIFE (2022)
ON-target Adverse Events of CRISPR-Cas9 Nuclease: More Chaotic than Expected
Julian Boutin et al.
CRISPR JOURNAL (2022)
An evaluation of patient-reported outcomes in sickle cell disease within a conceptual model
Marsha J. Treadwell et al.
QUALITY OF LIFE RESEARCH (2022)
High-level correction of the sickle mutation is amplified in vivo during erythroid differentiation
Wendy Magis et al.
ISCIENCE (2022)
Sickle Cell Disease: A Review
Patricia L. Kavanagh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)
A precise and efficient adenine base editor
Tianxiang Tu et al.
MOLECULAR THERAPY (2022)
Considerations for Selecting Cognitive Endpoints and Psychological Patient-Reported Outcomes for Clinical Trials in Pediatric Patients With Sickle Cell Disease
Anna M. Hood et al.
FRONTIERS IN NEUROLOGY (2022)
Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease
Paula Germino-Watnick et al.
CELLS (2022)
Real-World data on efficacy of L-glutamine in preventing sickle cell disease-related complications in pediatric and adult patients
Narcisse Elenga et al.
FRONTIERS IN MEDICINE (2022)
Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells
Samuele Ferrari et al.
CELL STEM CELL (2022)
Base-editing-mediated dissection of a γ-globin cis-regulatory element for the therapeutic reactivation of fetal hemoglobin expression
Panagiotis Antoniou et al.
NATURE COMMUNICATIONS (2022)
CRISPRthripsis: The Risk of CRISPR/Cas9-induced Chromothripsis in Gene Therapy
Mario Amendola et al.
STEM CELLS TRANSLATIONAL MEDICINE (2022)
Prioritizing Health-Sector Interventions for Noncommunicable Diseases and Injuries in Low- and Lower-Middle Income Countries: National NCDI Poverty Commissions
Neil Gupta et al.
GLOBAL HEALTH-SCIENCE AND PRACTICE (2021)
Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease
Erica B. Esrick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia
H. Frangoul et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Gene therapy for hemoglobinopathies
Yvette C. Tanhehco
TRANSFUSION AND APHERESIS SCIENCE (2021)
Influence of UGT1A1 promoter polymorphism, α-thalassemia and βs haplotype in bilirubin levels and cholelithiasis in a large sickle cell anemia cohort
Jessica V. G. F. Batista et al.
ANNALS OF HEMATOLOGY (2021)
Genome Editing for β-Hemoglobinopathies: Advances and Challenges
Giacomo Frati et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Haematological Care Priorities in Sub-Saharan Africa 2 Sickle cell disease in sub-Saharan Africa: transferable strategies for prevention and care
Kevin Esoh et al.
LANCET HAEMATOLOGY (2021)
Base editing of haematopoietic stem cells rescues sickle cell disease in mice
Gregory A. Newby et al.
NATURE (2021)
Development of β-globin gene correction in human hematopoietic stem cells as a potential durable treatment for sickle cell disease
Annalisa Lattanzi et al.
SCIENCE TRANSLATIONAL MEDICINE (2021)
Haploidentical Allogeneic Stem Cell Transplantation in Sickle Cell Disease: A Systematic Review and Meta-Analysis
Mesire Aydin et al.
TRANSPLANTATION AND CELLULAR THERAPY (2021)
Base and Prime Editing Technologies for Blood Disorders
Panagiotis Antoniou et al.
FRONTIERS IN GENOME EDITING (2021)
Curative options for sickle cell disease: haploidentical stem cell transplantation or gene therapy?
Alexis Leonard et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
The promise and challenge of therapeutic genome editing
Jennifer A. Doudna
NATURE (2020)
Evaluation and minimization of Cas9-independent off-target DNA editing by cytosine base editors
Jordan L. Doman et al.
NATURE BIOTECHNOLOGY (2020)
Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype
Leslie Weber et al.
SCIENCE ADVANCES (2020)
Directed evolution of adenine base editors with increased activity and therapeutic application
Nicole M. Gaudelli et al.
NATURE BIOTECHNOLOGY (2020)
Therapeutic base editing of human hematopoietic stem cells
Jing Zeng et al.
NATURE MEDICINE (2020)
A rationally engineered cytosine base editor retains high on-target activity while reducing both DNA and RNA off-target effects
Erwei Zuo et al.
NATURE METHODS (2020)
Myelodysplastic syndrome unrelated to lentiviral vector in a patient treated with gene therapy for sickle cell disease
Matthew M. Hsieh et al.
BLOOD ADVANCES (2020)
Cost of health care for paediatric patients with sickle cell disease: An analysis of resource use and costs in a European country
Frederick W. Thielen et al.
PEDIATRIC BLOOD & CANCER (2020)
Base editing: advances and therapeutic opportunities
Elizabeth M. Porto et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Adenosine Base Editing of γ-Globin Promoters Induces Fetal Hemoglobin and Inhibit Erythroid Sickling
Thiyagaraj Mayuranathan et al.
BLOOD (2020)
Early Results from a Phase 1/2 Study of Aru-1801 Gene Therapy for Sickle Cell Disease (SCD): Manufacturing Process Enhancements Improve Efficacy of a Modified Gamma Globin Lentivirus Vector and Reduced Intensity Conditioning Transplant
Michael Grimley et al.
BLOOD (2020)
Cytosine base editor 4 but not adenine base editor generates off-target mutations in mouse embryos
Hye Kyung Lee et al.
COMMUNICATIONS BIOLOGY (2020)
Precise Gene Editing Preserves Hematopoietic Stem Cell Function following Transient p53-Mediated DNA Damage Response
Giulia Schiroli et al.
CELL STEM CELL (2019)
Innovative Curative Treatment of Beta Thalassemia: Cost-Efficacy Analysis of Gene Therapy Versus Allogenic Hematopoietic Stem-Cell Transplantation
Severine Coquerelle et al.
HUMAN GENE THERAPY (2019)
Cytosine base editor generates substantial off-target single-nucleotide variants in mouse embryos
Erwei Zuo et al.
SCIENCE (2019)
Cytosine, but not adenine, base editors induce genome-wide off-target mutations in rice
Shuai Jin et al.
SCIENCE (2019)
Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease
Barbara Cappelli et al.
HAEMATOLOGICA (2019)
Transcriptome-wide off-target RNA editing induced by CRISPR-guided DNA base editors
Julian Grunewald et al.
NATURE (2019)
Off-target RNA mutation induced by DNA base editing and its elimination by mutagenesis
Changyang Zhou et al.
NATURE (2019)
A Phase 3 Randomized Trial of Voxelotor in Sickle Cell Disease
Elliott Vichinsky et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Search-and-replace genome editing without double-strand breaks or donor DNA
Andrew V. Anzalone et al.
NATURE (2019)
The epidemiology of sickle cell disease in children recruited in infancy in Kilifi, Kenya: a prospective cohort study
Sophie Uyoga et al.
LANCET GLOBAL HEALTH (2019)
Genetic Modifiers of Fetal Haemoglobin in Sickle Cell Disease
Stephan Menzel et al.
MOLECULAR DIAGNOSIS & THERAPY (2019)
Genome editing of HBG1 and HBG2 to induce fetal hemoglobin
Jean-Yves Metais et al.
BLOOD ADVANCES (2019)
Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch
Nan Liu et al.
CELL (2018)
Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion
Chantal Lagresle-Peyrou et al.
HAEMATOLOGICA (2018)
Global Transcriptional Response to CRISPR/Cas9-AAV6-Based Genome Editing in CD34+ Hematopoietic Stem and Progenitor Cells
M. Kyle Cromer et al.
MOLECULAR THERAPY (2018)
Repair of double-strand breaks induced by CRISPR-Cas9 leads to large deletions and complex rearrangements
Michael Kosicki et al.
NATURE BIOTECHNOLOGY (2018)
Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding
Gabriella E. Martyn et al.
NATURE GENETICS (2018)
p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells
Robert J. Ihry et al.
NATURE MEDICINE (2018)
CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response
Emma Haapaniemi et al.
NATURE MEDICINE (2018)
A Phase 3 Trial of L-Glutamine in Sickle Cell Disease
Yutaka Niihara et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia
A. A. Thompson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Plerixafor enables safe, rapid, efficient mobilization of hematopoietic stem cells in sickle cell disease patients after exchange transfusion
Chantal Lagresle-Peyrou et al.
HAEMATOLOGICA (2018)
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cells
Christopher A. Vakulskas et al.
NATURE MEDICINE (2018)
Newborn screening for sickle cell disease in Europe: recommendations from a Pan-European Consensus Conference
Stephan Lobitz et al.
BRITISH JOURNAL OF HAEMATOLOGY (2018)
Human hemoglobin G-Makassar variant masquerading as sickle cell anemia
Ahmad Sabry Mohamad et al.
HEMATOLOGY REPORTS (2018)
Gene Therapy in a Patient with Sickle Cell Disease
Jean-Antoine Ribeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Improving the DNA specificity and applicability of base editing through protein engineering and protein delivery
Holly A. Rees et al.
NATURE COMMUNICATIONS (2017)
Increased risk of leukemia among sickle cell disease patients in California
Ann Brunson et al.
BLOOD (2017)
Treating sickle cell disease by targeting HbS polymerization
William A. Eaton et al.
BLOOD (2017)
Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease
Mark C. Walters et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2016)
Gene Therapy of the β-Hemoglobinopathies by Lentiviral Transfer of the βA(T87Q)-Globin Gene
Olivier Negre et al.
HUMAN GENE THERAPY (2016)
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P. Dever et al.
NATURE (2016)
A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition
Elizabeth A. Traxler et al.
NATURE MEDICINE (2016)
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
Mark A. DeWitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies Using a Reduced-Intensity Conditioning Regimen and Third-Party Mesenchymal Stromal Cells
Sandhya Kharbanda et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2014)
Association of Variants at BCL11A and HBS1L-MYB with Hemoglobin F and Hospitalization Rates among Sickle Cell Patients in Cameroon
Ambroise Wonkam et al.
PLOS ONE (2014)
The Co-Inheritance of Alpha-Thalassemia and Sickle Cell Anemia Is Associated with Better Hematological Indices and Lower Consultations Rate in Cameroonian Patients and Could Improve Their Survival
Maryam Bibi Rumaney et al.
PLOS ONE (2014)
After the Introduction into the National Newborn Screening Program: Who Is Receiving Genetic Counseling for Hemoglobinopathies in The Netherlands?
J. O. Kaufmann et al.
PUBLIC HEALTH GENOMICS (2014)
The BET Family of Proteins Targets Moloney Murine Leukemia Virus Integration near Transcription Start Sites
Jan De Rijck et al.
CELL REPORTS (2013)
Global Burden of Sickle Cell Anaemia in Children under Five, 2010-2050: Modelling Based on Demographics, Excess Mortality, and Interventions
Frederic B. Piel et al.
PLOS MEDICINE (2013)
High resource hospitalizations among children with vaso-occlusive crises in sickle cell disease
Jean L. Raphael et al.
PEDIATRIC BLOOD & CANCER (2012)
Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management
Erfan Nur et al.
AMERICAN JOURNAL OF HEMATOLOGY (2011)
Inhibition of cell adhesion by anti-P-selectin aptamer: a new potential therapeutic agent for sickle cell disease
Diana R. Gutsaeva et al.
BLOOD (2011)
Global distribution of the sickle cell gene and geographical confirmation of the malaria hypothesis
Frederic B. Piel et al.
NATURE COMMUNICATIONS (2010)
Maternal Knowledge and Attitudes About Newborn Screening for Sickle Cell Disease and Cystic Fibrosis
Colleen Walsh Lang et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
Identification of genetic polymorphisms associated with risk for pulmonary hypertension in sickle cell disease
Allison E. Ashley-Koch et al.
BLOOD (2008)
Sickle Cell Anemia, the First Molecular Disease: Overview of Molecular Etiology, Pathophysiology, and Therapeutic Approaches
Martin H. Steinberg
THESCIENTIFICWORLDJOURNAL (2008)
The linear effects of α-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease
Nisha Vasavda et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
cMYB is involved in the regulation of fetal hemoglobin production in adults
Jie Jiang et al.
BLOOD (2006)
A case for developing North-South partnerships for research in sickle cell disease
D Weatherall et al.
BLOOD (2005)
Malignancy in patients with sickle cell disease
WH Schultz et al.
AMERICAN JOURNAL OF HEMATOLOGY (2003)
Looping and interaction between hypersensitive sites in the active β-globin locus
B Tolhuis et al.
MOLECULAR CELL (2002)
Hb G-Makassar [beta 6(A3)Glu -> Ala; codon 6 (GAG -> GCG)]: Molecular characterization, clinical, and hematological effects
V Viprakasit et al.
HEMOGLOBIN (2002)
Role of epistatic (modifier) genes in the modulation of the phenotypic diversity of sickle cell anemia
RL Nagel et al.
PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE (2001)
Pharmacologic induction of fetal hemoglobin synthesis: Cellular and molecular mechanisms
YM Yang et al.
PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE (2001)
分享论文
